We are live on ! Find out more
ITCI

Intra-Cellular Therapies Inc.
ITCI

Delisted

ITCI was delisted on the 1st of April, 2025.

Back to rankings

208 hedge funds and large institutions have $3.59B invested in Intra-Cellular Therapies Inc. in 2021 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 57 increasing their positions, 67 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more funds holding in top 10

Funds holding in top 10: 3 → 8 (+5)

143% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 21

117% more call options, than puts

Call options by funds: $68.2M | Put options by funds: $31.4M

41% more capital invested

Capital invested by funds: $2.55B → $3.59B (+$1.04B)

16% more funds holding

Funds holding: 180 → 208 (+28)

15% less repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 67

Holders
208
Holders Change
+28
Holders Change %
+15.56%
% of All Funds
3.2%
Holding in Top 10
8
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+166.67%
% of All Funds
0.12%
New
51
Increased
57
Reduced
67
Closed
21
Calls
$68.2M
Puts
$31.4M
Net Calls
+$36.7M
Net Calls Change
+$13.4M

Top Buyers

Rank Fund Capital Flow
1
PAMS
Pictet Asset Management (Switzerland)
Switzerland
+$61.1M
2
GKIM
GW&K Investment Management
Massachusetts
+$15.7M
3
Deutsche Bank
Deutsche Bank
Germany
+$13.3M
4
Two Sigma Investments
Two Sigma Investments
New York
+$11.7M
5
Norges Bank
Norges Bank
Norway
+$9.48M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$17.9M
2
TCM
TimesSquare Capital Management
New York
-$15.7M
3
CS
Candriam SCA
Luxembourg
-$15.5M
4
Goldman Sachs
Goldman Sachs
New York
-$14.8M
5
Franklin Resources
Franklin Resources
California
-$11.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
LPL Financial
126
LPL Financial
California
$745K -$28.4K -676 -5%
NIM
127
NXG Investment Management
Texas
$710K +$249K +5,928 +78%
Teacher Retirement System of Texas
128
Teacher Retirement System of Texas
Texas
$699K +$112K +2,666 +25%
SLT
129
St Louis Trust
Missouri
$674K +$541K +12,870 New
GAM
130
Gemmer Asset Management
California
$654K – – –
Allianz Asset Management
131
Allianz Asset Management
Germany
$652K – – –
AB
132
Amalgamated Bank
New York
$651K -$5.67K -135 -1%
Zurich Cantonal Bank
133
Zurich Cantonal Bank
Switzerland
$604K +$114K +2,724 +31%
QT
134
Quantbot Technologies
New York
$604K +$485K +11,554 New
Two Sigma Advisers
135
Two Sigma Advisers
New York
$600K +$482K +11,467 New
SWM
136
SeaCrest Wealth Management
New York
$559K +$448K +10,674 New
Natixis Advisors
137
Natixis Advisors
Massachusetts
$555K +$446K +10,607 New
CG
138
Cutler Group
California
$554K +$400K +9,513 +887%
VEA
139
Virtus ETF Advisers
New York
$545K -$11.9K -284 -3%
Public Employees Retirement Association of Colorado
140
Public Employees Retirement Association of Colorado
Colorado
$542K – – –
PCM
141
Prelude Capital Management
New York
$534K -$160K -3,802 -27%
Group One Trading
142
Group One Trading
Illinois
$499K -$760K -18,087 -65%
American Century Companies
143
American Century Companies
Missouri
$498K +$37.2K +886 +10%
Rafferty Asset Management
144
Rafferty Asset Management
New York
$464K -$28.7K -683 -7%
TSS
145
Two Sigma Securities
New York
$459K +$369K +8,779 New
AC
146
Avestar Capital
New York
$450K -$33.9K -807 -9%
AQR Capital Management
147
AQR Capital Management
Connecticut
$446K – – –
SO
148
STRS Ohio
Ohio
$434K +$37.8K +900 +12%
Nisa Investment Advisors
149
Nisa Investment Advisors
Missouri
$421K +$1.97K +47 +0.5%
GC
150
Guggenheim Capital
Illinois
$402K +$323K +7,691 New
4 5
6
7 8

ITCI Hedge Fund Activity: Q4 2021 in Review

208 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Intra-Cellular Therapies Inc. (ITCI) for Q4 2021, worth a combined $3.59B — up 41% from $2.55B a quarter earlier.

Buyers outnumbered sellers: 51 funds opened new ITCI positions and 21 closed out — a net gain of 30 holders — while 57 added to existing stakes and 67 trimmed.

The largest buyer was Pictet Asset Management (Switzerland), opening a new position worth an estimated $61.1M. The largest seller was Citadel Advisors, cutting an estimated $17.9M.

  • 208 institutional investors held Intra-Cellular Therapies Inc. (ITCI) as of Q4 2021, up from 180 in Q3 2021.
  • Funds reported $3.59B of Intra-Cellular Therapies Inc. stock for Q4 2021, up 41% quarter-over-quarter.
  • 51 funds opened new Intra-Cellular Therapies Inc. positions in Q4 2021 and 21 closed out, a net change of +30 holders.
  • The largest Intra-Cellular Therapies Inc. buyer in Q4 2021 was Pictet Asset Management (Switzerland), an estimated $61.1M added.
  • The largest Intra-Cellular Therapies Inc. seller in Q4 2021 was Citadel Advisors, an estimated $17.9M sold.

Based on aggregated 13F filings for Q4 2021.